drugset / Trial / NCT00667368

Bacterial Vaginosis Home Screening to Prevent STDs

NCT00667368

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether regular screening (every 2 months) and treatment for bacterial vaginosis (BV \[infection of the vagina\]) will reduce the number of incidences of chlamydia and gonorrhea (sexually transmitted diseases) over the course of a year. Chlamydial and gonococcal infections will be determined by vaginal swab testing at 4, 8, and 12 months after enrollment. Subjects will include 1500 women aged 15-25 years who have clinical evidence of BV, with no symptoms. Subjects will be randomly assigned to 1 of 2 possible study groups: the intervention group (treatment of BV) or the control group (no BV treatment). Every 2 months, subjects will complete a home self-testing kit for screening of BV using a swab. If BV is detected by self-test, the subjects in the interventional group will receive a 7 day course of the antibiotic metronidazole. Participants will be involved in study related procedures for up to 12 months.

Timeline

Start
2008-07-28
Primary completion
2014-12-31
Completion
2014-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 500 mg Oral

Indications